About ViaeX Technologies
ViaeX Technologies is a company based in San Francisco (United States) founded in 2016 by Hudson Liao. ViaeX Technologies has raised $4.25 million across 2 funding rounds from investors including IndieBio. ViaeX Technologies operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter San Francisco, United States
- Founders Hudson Liao
- SectorsEnvironmentHealthcare Technology
- Email••••••••
- Website viaextechnologies.com
- Social LinkedIn X Facebook
- Total Equity Funding$4.25M (USD)
in 2 rounds
- Latest Funding Round$4M (USD), Series A
Aug 2017
- Investors
Funding Insights of ViaeX Technologies
ViaeX Technologies has successfully raised a total of $4.25M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.25M
- Total Rounds 2
- Last Round Series A — $4M
- First Round $250,000
(Oct 2016)
- Investors Count 1
All 2 funding rounds of ViaeX Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2017 | $4M | Series A | – | – | – |
| Oct 2016 | $250,000 | Series A | – | IndieBio | – |
1 investors in total: 1 institutional.
Investors in ViaeX Technologies
ViaeX Technologies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech startups are accelerated through IndieBio's focused programs. | – | indiebio.co | San Francisco, United States |
Investor details for ViaeX Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ViaeX Technologies
1 people are tracked at ViaeX Technologies (1 in leadership).
| Name | Role | Group |
|---|---|---|
Hudson Liao | Co-Founder | Leadership |
Complete people profiles for ViaeX Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ViaeX Technologies
3 dated milestones of ViaeX Technologies across 1 years, from founding to its latest funding, stage changes and deals.
- Founded ViaeX Technologies is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Series A, of $4.0M.
Competitors of ViaeX Technologies
ViaeX Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| lifeminetx.com | 2016 | Cambridge, United States | $300.07M | 85 | Developer of novel drugs from fungi via genome mining and recombinant overexpression |
Detailed competitors of ViaeX Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to ViaeX Technologies
10 companies that operate in the same segment as ViaeX Technologies (Waste & Water Management Systems), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Wastewater and energy management services are provided internationally. | 1853 | Aubervilliers, Seine-saint-denis, France | – | USD 52.17 B | 215,040 | |
Sustainable infrastructure solutions in renewable energy are developed and managed. | 1931 | Alcobendas, Comunidad De Madrid, Spain | – | USD 1.9 M | 44 | |
Provider of climate-smart deeptech solutions for renewable energy and sustainable agriculture | 2010 | Pune, Maharashtra, India | USD 76.38 M | USD 56.11 M | 702 | |
Waste collection and management services are provided nationwide. | 1968 | Houston, Texas, United States | – | USD 25.2 B | 61,700 | |
Integrated waste management services are provided nationwide. | 1998 | Phoenix, Arizona, United States | – | USD 16.59 B | 42,000 | |
Provider of smart water purifier rental and maintenance services | 2016 | Bengaluru, Karnataka, India | USD 19.29 M | USD 3.62 M | – | |
Sensor-based sorting and recycling solutions are provided for multiple industries. | 1972 | Asker, Viken, Norway | – | USD 1.53 B | 4,950 | |
Smart water dispensers with flavored options are provided for offices. | 2013 | Boston, Massachusetts, United States | USD 135.53 M | – | 102 | |
Surplus goods are shared among neighbors through a mobile app. | 2015 | London, England, United Kingdom | USD 51.2 M | – | – | |
Water and waste treatment services are provided worldwide. | 1966 | London, England, United Kingdom | – | USD 4.18 B | 9,750 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ViaeX Technologies
ViaeX Technologies was founded in 2016.
ViaeX Technologies is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
ViaeX Technologies is a funded company, having raised a total of $4.25M across 2 funding rounds to date. The company's 1st funding round was a Series A of $250K, raised on Oct 2016.
ViaeX Technologies was founded in 2016 in San Francisco, United States, within the nanomaterials and filtration sector. Algorithms and chemistries are utilized to convert biodegradable chitosan biowaste into customized nanomaterials. These materials support applications in water purification, industrial separation, skincare, food and beverage filtration, and wound healing. Operations focus on cross-industry solutions for sustainable processing.
ViaeX Technologies's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
ViaeX Technologies has 1 investor. Key investors include IndieBio.